Around 500 mn people will develop heart disease, obesity, diabetes or other non-communicable diseases (NCDs) due to physical inactivity, WHO's 'Global Status Report on Physical Activity 2022' says
About 92% of cases in India are said to be having mild disease. In only 5.8% of cases oxygen therapy is required, intensive care in only 1.7% cases
Glenmark Pharmaceuticals on Thursday said it has launched Thiazolidinedione Lobeglitazone in the country for the treatment of type 2 diabetes in adults. The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet. Indians have a high prevalence of insulin resistance and that makes LOBG an appealing treatment option in managing uncontrolled Type 2 diabetes among insulin-resistant diabetic patients, Glenmark Pharmaceuticals said in a statement. The company had received approval from the Indian drug regulator, Drug Controller General of India, for manufacturing and marketing Lobeglitazone, based on a randomised, double-blind Phase 3 clinical trial conducted on adult Type 2 diabetic patients, aged 18 years and older. "As per the International Diabetes Federation, diabetes affects 74 million adults in India, of which, around 40 per cent of them seem to be insulin-resistant... "We are proud to introduce LOBG; an innovative an
Lancet study: Alzheimer's and other dementias claimed 129,000 lives in 2019
In the last 24 hours, India reported 3,805 fresh Covid-19 cases ad 26 deaths, the Union Health Ministry said on Saturday.
By 2040, Type 1 diabetes cases to increase by 116% in India, says Lancet study
Experts say India needs more decentralised planning, and access to testing and treatment for malaria and dengue
Infections treated with speciality hospital care in early and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), according to a new study.
Doctors have often attributed a cardiac arrest to factors like diabetes, hypertension, smoking and alcohol intake, along with erratic lifestyle and lack of sleep
Ashish will lead Business growth strategy, business partnerships and network expansion for Zyla Health.
The findings suggest that blood testing for endotrophin may eventually become a standard part of cardiologists' toolkits for assessing heart failure patients
T2D is a chronic and progressive condition in which the body does not make or use insulin normally, leading to high levels of glucose in the blood
The new therapy, described Sept. 12 in Cell Cancer, pulls a mutated version of the protein KRAS to the surface of cancer cells, where the drug-KRAS complex acts as an "eat me" flag
"These hits to the head are hard to study because much of it depends on recall of an injury since the impacts do not all require a visit to a doctor," said Daniel Lopez
Over 50 distinct cancer kinds each have a common cancer signal that new MCED tests being developed will be able to identify and pinpoint where in the body the signal originated
Zenara Pharma had received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market this product last month
Research led by Caroline Crowther of the University of Auckland, New Zealand, and a team, the findings were published in the journal PLOS Medicine
The surface of a cell, which is covered with tens to hundreds of thousands of molecules that assist immune cells to distinguish friend from foe, can reveal a cell's secrets.
OCD is a mental illness involving anxiety, characterized by intrusive and repetitious thoughts, called obsessions, coupled with certain repeated actions, known as compulsions
Students can visit the official websites of the board i.e. cetcell.mahacet.org to check the answers